• Zum Hauptinhalt springen
  • Zum Footer springen

PSY-PGx

  • About
    • Mission
    • Management & Structure
  • Consortium
  • Research
    • Work Packages
    • Careers
    • Publications
    • Clinical Study
  • Patients
    • Local Websites
    • Clinical Study
  • Media
    • Patient Experiences with Pharmacogenetics
    • Press Releases
    • Patient Inclusion
    • X (formerly Twitter)
  • Internal
  • Events
  • Meet the Team
  • News
  1. PSY-PGx
  2. Research
  3. Work Packages
  4. WP1A: Study Set-up Genetics

WP1A: Study Set-up Genetics

Lead

Farmaceutski Fakultet Univerzitetau Beogradu

Faculty of Pharmacy

Prof. Marin Jukic

Universitätsklinikum Bonn

Institute of Human Genetics

Prof. Markus Nöthen

Participants/Support

  • Karolinska Institute
  • Parnassia Groep BV

Goals

  • Establish logistics for sample collection, processing, storage and shipment at the clinical centers as well as effective communication between clinical centers and the central facilities
  • Building of the PSY-PGx DNA biobank
  • Development of a PSY-PGx cellular biobank
  • Perform genotyping for common genetic variants throughout the clinical trial
  • Perform retrospective therapeutic drug level quantification
  • Interpretations of the results obtained in collaboration with WP5 (Clinical Study)

PSY-PGx

A New Intervention for Implementation of Pharmacogenetics in Psychiatry
PSY-PGx Coordinator

Roos van Westrhenen

Psychiatrist & Clinical Pharmacologist (MD, PhD) Parnassia Psychiatric Institute/St. John’s National Academy of Health Sciences, Bangalore, India/King’s College London

Overschiestraat 57
1062 HN Amsterdam, The Netherlands
p qguédicbpWziuiuöYYcјæ uä

Sitemap

About
Consortium Members
Research
Patients
News
Internal


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 945151.

Twitter
Editor login
Imprint | Data-Safety